tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
Ver gráfico detalhado
2.070USD
0.0000.00%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
95.54MValor de mercado
PerdaP/L TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Hoje

0.00%

5 Dias

0.00%

1 Mês

0.00%

6 Meses

+9.52%

Ano até a data

0.00%

Um ano

+307.48%

Ver gráfico detalhado

Avaliação de Ações TradingKey

Nenhuma avaliação de ações disponível devido à insuficiência de dados.

Immunoprecise Antibodies Ltd Notícias

Mais notícias em breve, fique ligado...

Indicadores Financeiros

EPS

Os dados relevantes ainda não foram divulgados pela empresa.

Receita Total

Os dados relevantes ainda não foram divulgados pela empresa.

Informações de Immunoprecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Código da empresaIPA
EmpresaImmunoprecise Antibodies Ltd
CEODr. Jennifer Lynne Bath, Ph.D.
Sitehttps://www.ipatherapeutics.com/
KeyAI